M. L. Ballinger, G. Mitchell, and D. M. Thomas, Surveillance recommendations for patients with germline TP53 mutations, Curr Opin Oncol, vol.27, issue.4, pp.332-337, 2015.

V. J. Bykov and K. G. Wiman, Mutant p53 reactivation by small molecules makes its way to the clinic, FEBS Lett, vol.588, issue.16, pp.2622-2627, 2014.

M. Chen and J. L. Manley, Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches, Nat Rev Mol Cell Biol, vol.10, issue.11, pp.741-754, 2009.

H. Döhner, E. Estey, D. Grimwade, S. Amadori, F. R. Appelbaum et al., Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel, Blood, vol.129, issue.4, pp.424-447, 2017.

K. Edlund, O. Larsson, A. Ameur, I. Bunikis, U. Gyllensten et al., Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors, Proc Natl Acad Sci U S A, vol.109, issue.24, pp.9551-9556, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01188067

L. Fernandez-cuesta, S. Perdomo, P. H. Avogbe, N. Leblay, T. M. Delhomme et al., Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer, EBioMedicine, vol.10, pp.117-123, 2016.

S. Goodwin, J. D. Mcpherson, and W. R. Mccombie, Coming of age: ten years of next-generation sequencing technologies, Nat Rev Genet, vol.17, issue.6, pp.333-351, 2016.

R. Holmila, C. Fouquet, J. Cadranel, G. Zalcman, and T. Soussi, Splice mutations in the p53 gene: case report and review of the literature, Hum Mutat, vol.21, issue.1, pp.101-102, 2003.

S. M. Joruiz and J. C. Bourdon, p53 Isoforms: Key Regulators of the Cell Fate Decision, Cold Spring Harb Perspect Med, vol.6, issue.8, 2016.

S. Kato, S. Y. Han, W. Liu, K. Otsuka, H. Shibata et al., Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis, Proc Natl Acad Sci U S A, vol.100, issue.14, pp.8424-8429, 2003.

K. H. Khoo, K. K. Hoe, C. S. Verma, and D. P. Lane, Drugging the p53 pathway: understanding the route to clinical efficacy, Nat Rev Drug Discov, vol.13, issue.3, pp.217-236, 2014.

M. P. Khoury and J. C. Bourdon, The isoforms of the p53 protein, Cold Spring Harb Perspect Biol, vol.2, issue.3, p.927, 2010.

Y. Kobayashi, S. Yang, K. Nykamp, J. Garcia, S. E. Lincoln et al., Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation, Genome Med, vol.9, issue.1, p.13, 2017.

J. D. Krimmel, M. W. Schmitt, M. I. Harrell, K. J. Agnew, S. R. Kennedy et al., Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues, Proc Natl Acad Sci, vol.113, issue.21, pp.6005-6010, 2016.

B. Leroy, M. Anderson, and T. Soussi, TP53 mutations in human cancer: database reassessment and prospects for the next decade, Hum Mutat, vol.35, issue.6, pp.672-688, 2014.

B. Leroy, M. L. Ballinger, F. Baran-marszak, G. L. Bond, A. Braithwaite et al., Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice, Cancer Res, vol.6, pp.1250-1260, 2017.

X. Liu, C. Wu, C. Li, and E. Boerwinkle, dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs, Hum Mutat, vol.37, issue.3, pp.235-241, 2016.

E. M. Makarov, T. A. Shtam, R. A. Kovalev, R. A. Pantina, E. Y. Varfolomeeva et al., The rare nonsense mutation in p53 triggers alternative splicing to produce a protein capable of inducing apoptosis, PLoS One, vol.12, issue.9, 2017.

J. Malcikova, E. Tausch, D. Rossi, L. A. Sutton, T. Soussi et al.,

O. C. , ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation, Leukemia, 2018.

F. T. Merkle, S. Ghosh, N. Kamitaki, J. Mitchell, Y. Avior et al., Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations, Nature, vol.545, issue.7653, pp.229-233, 2017.

J. Phallen, M. Sausen, V. Adleff, A. Leal, C. Hruban et al.,

V. E. Velculescu, Direct detection of early-stage cancers using circulating tumor DNA, Sci Transl Med, issue.403, p.9, 2017.

S. Pospisilova, D. Gonzalez, J. Malcikova, M. Trbusek, D. Rossi et al., ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia, Leukemia, vol.26, issue.7, pp.1458-1461, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02318055

S. Richards, N. Aziz, S. Bale, D. Bick, S. Das et al.,

A. C. Committee,

M. G. , Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med, vol.17, issue.5, pp.405-424, 2015.

T. Soussi, Locus-specific databases in cancer: what future in a post-genomic era? The TP53 LSDB paradigm, Hum Mutat, vol.35, issue.6, pp.643-653, 2014.

T. Soussi, B. Leroy, and P. E. Taschner, Recommendations for analyzing and reporting TP53 gene variants in the high-throughput sequencing era, Hum Mutat, vol.35, issue.6, pp.766-778, 2014.

T. Soussi, P. E. Taschner, and Y. Samuels, Synonymous Somatic Variants in Human Cancer Are Not Infamous: A Plea for Full Disclosure in Databases and Publications, Hum Mutat, vol.38, issue.4, pp.339-342, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02318074

T. Soussi and K. G. Wiman, TP53: an oncogene in disguise, Cell Death Differ, vol.22, issue.8, pp.1239-1249, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01188060

P. E. Taschner and J. T. Den-dunnen, Describing structural changes by extending HGVS sequence variation nomenclature, Hum Mutat, vol.32, issue.5, pp.507-511, 2011.

A. Trounson, Potential Pitfall of Pluripotent Stem Cells, N Engl J Med, vol.377, issue.5, pp.490-491, 2017.

J. M. Varley, G. Mcgown, M. Thorncroft, G. R. White, K. J. Tricker et al., A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier, Br J Cancer, vol.78, issue.8, pp.1081-1083, 1998.

M. Wildeman, E. Van-ophuizen, J. T. Den-dunnen, and P. E. Taschner, Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker, Hum Mutat, vol.29, issue.1, pp.6-13, 2008.

J. L. Yen, S. Garcia, A. Montana, J. Harris, S. Chervitz et al., A variant by any name: quantifying annotation discordance across tools and clinical databases, Genome Med, vol.9, issue.1, p.7, 2017.